RSS

immune-oncology

Global drug discovery and development services company, Crown Bioscience, has extended its existing portfolio of humanised drug target models (HuGEMM) to its San Diego facility. Read more

News

ProBioGen (service and technology provider for complex therapeutic glycoproteins) and Pionyr Immunotherapeutics have initiated a second immune-oncology contract development and manufacturing project. Read more

News

A consortium has been launched by Certara for the development of a quantitative systems pharmacology immune-oncology simulator to test combination cancer therapies and different dose regimens and biomarkers in computer-generated, virtual patients Read more

News

German service and technology provider, ProBioGen, and immune-oncology company, Surface Oncology, have signed a second antibody development project for the development and manufacture of another antibody for potential use in clinical trials. Read more

News

UK-based synthetic biology company, Prokarium, has completed an investment round, raising $10 million for the clinical development of vaccines against chlamydia, C.difficile and enteric fever, plus an expansion for the immune-oncology R&D team Read more

News

Horizon Discovery Group, gene editing and modulation technologies company, has entered into a non-exclusive out-licensing agreement with a US-based immune-oncology therapeutics developer. Read more

News

Two biotech companies, APEIRON and Evotec, have received the first milestone payment from Sanofi as part of the three-party immune-oncology alliance that was signed in 2015. Read more

News

An immune-oncology focused biotechnology company, BriaCell, has provided a clinical update on its lead immunotherapy drug for advanced breast cancer. Read more

News

Biotech company Scholar Rock has closed a $47 million Series C financing round, which will be used to advance its innovative pipeline for spinal muscular atrophy (SMA), immune-oncology, fibrosis and iron-restricted anaemias. Read more

News